| Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems for infectious diseases; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| LANE ANDREW H | Executive Vice President | May 05 | Option Exercise | 43.82 | 80,000 | 3,505,314 | 145,822 | May 07 05:02 PM | | LANE ANDREW H | Executive Vice President | May 05 | Sale | 92.00 | 80,000 | 7,360,104 | 65,822 | May 07 05:02 PM | | WOODGRIFT RANDEL WILLIAM | Senior Vice President | Apr 28 | Sale | 93.18 | 3,724 | 347,012 | 48,767 | Apr 30 06:34 PM | | CAPEK JOHN M | Executive Vice President | Apr 21 | Option Exercise | 22.39 | 50,100 | 1,121,834 | 366,900 | Apr 23 09:34 PM | | Ginascol John F | Executive Vice President | Apr 21 | Option Exercise | 38.40 | 63,200 | 2,426,880 | 129,645 | Apr 23 09:41 PM | | Funck Robert E | Executive Vice President & CFO | Apr 21 | Option Exercise | 36.42 | 36,700 | 1,336,638 | 206,072 | Apr 23 09:27 PM | | Contreras Jaime | Senior Vice President | Apr 21 | Option Exercise | 57.12 | 108,412 | 6,192,995 | 145,431 | Apr 23 09:26 PM | | Scoggins Christopher J | Senior Vice President | Apr 21 | Sale | 96.10 | 414 | 39,785 | 39,706 | Apr 23 09:28 PM | | Ginascol John F | Executive Vice President | Apr 21 | Sale | 96.00 | 63,200 | 6,067,051 | 66,445 | Apr 23 09:41 PM | | CAPEK JOHN M | Executive Vice President | Apr 21 | Sale | 95.87 | 50,100 | 4,803,326 | 316,800 | Apr 23 09:34 PM | | Boudreau Philip P | Vice President | Mar 13 | Sale | 82.00 | 10,600 | 869,200 | 22,463 | Mar 16 06:47 PM | | Watkin Jared | Senior Vice President | Mar 06 | Sale | 82.00 | 8,248 | 676,336 | 68,696 | Mar 10 05:06 PM | | BIRD ROGER | Senior Vice President | Mar 02 | Sale | 77.89 | 666 | 51,875 | 62,920 | Mar 03 05:23 PM | | DALE MICHAEL D | Senior Vice President | Mar 02 | Sale | 77.89 | 787 | 61,299 | 34,763 | Mar 03 05:21 PM | | Ginascol John F | Executive Vice President | Mar 02 | Sale | 77.63 | 6,606 | 512,805 | 66,445 | Mar 03 05:20 PM | | Contreras Jaime | Senior Vice President | Mar 02 | Sale | 77.89 | 2,001 | 155,858 | 37,019 | Mar 03 05:19 PM | | Watkin Jared | Senior Vice President | Mar 02 | Sale | 77.89 | 1,761 | 137,164 | 76,944 | Mar 03 05:19 PM | | ALLEN HUBERT L | Executive Vice President | Mar 02 | Sale | 77.89 | 1,208 | 94,091 | 151,896 | Mar 03 05:16 PM | | Scoggins Christopher J | Senior Vice President | Mar 02 | Sale | 77.89 | 1,240 | 96,584 | 41,168 | Mar 03 05:15 PM | | Salvadori Daniel Gesua Sive | Executive Vice President | Mar 02 | Sale | 77.89 | 999 | 77,812 | 103,493 | Mar 03 05:16 PM | | BRYNELSEN CHARLES | Senior Vice President | Mar 02 | Sale | 77.89 | 1,781 | 138,722 | 45,460 | Mar 03 05:13 PM | | Wainer Andrea F | Executive Vice President | Mar 02 | Sale | 77.89 | 1,429 | 111,305 | 49,498 | Mar 03 05:10 PM | | Funck Robert E | Executive Vice President & CFO | Mar 02 | Sale | 77.89 | 1,356 | 105,619 | 169,372 | Mar 03 05:28 PM | | WOODGRIFT RANDEL WILLIAM | Senior Vice President | Mar 02 | Sale | 77.89 | 1,420 | 110,604 | 53,859 | Mar 03 05:27 PM | | Moreland Mary K | Executive Vice President | Feb 25 | Sale | 84.93 | 400 | 33,972 | 66,131 | Feb 25 05:29 PM | | Moreland Mary K | Executive Vice President | Feb 19 | Sale | 88.97 | 1,019 | 90,660 | 52,985 | Feb 19 05:53 PM | | DALE MICHAEL D | Senior Vice President | Feb 19 | Sale | 88.97 | 396 | 35,232 | 23,947 | Feb 19 05:53 PM | | Wainer Andrea F | Executive Vice President | Feb 07 | Sale | 88.61 | 1,120 | 99,245 | 40,140 | Feb 11 06:10 PM | | YOOR BRIAN B | Executive Vice President & CFO | Jan 28 | Option Exercise | 45.33 | 509,850 | 23,110,674 | 624,231 | Jan 30 05:23 PM | | YOOR BRIAN B | Executive Vice President & CFO | Jan 28 | Sale | 89.73 | 509,850 | 45,747,209 | 114,381 | Jan 30 05:23 PM | | MANNING JOSEPH J | Senior Vice President | Jan 27 | Option Exercise | 38.40 | 37,500 | 1,440,000 | 88,032 | Jan 29 05:06 PM | | MANNING JOSEPH J | Senior Vice President | Jan 27 | Sale | 89.58 | 37,500 | 3,359,411 | 50,534 | Jan 29 05:06 PM | | WOODGRIFT RANDEL WILLIAM | Senior Vice President | Oct 23 | Option Exercise | 38.40 | 16,000 | 614,400 | 68,562 | Oct 25 05:02 PM | | WOODGRIFT RANDEL WILLIAM | Senior Vice President | Oct 23 | Sale | 80.54 | 21,000 | 1,691,315 | 47,562 | Oct 25 05:02 PM | | MANNING JOSEPH J | Senior Vice President | Aug 30 | Option Exercise | 47.00 | 47,226 | 2,219,622 | 97,755 | Sep 04 05:20 PM | | MANNING JOSEPH J | Senior Vice President | Aug 30 | Sale | 85.14 | 47,226 | 4,020,685 | 50,532 | Sep 04 05:20 PM | | PEDERSON MICHAEL J | Senior Vice President | Aug 09 | Option Exercise | 50.72 | 23,008 | 1,166,966 | 104,228 | Aug 13 07:12 PM | | Funck Robert E | Senior Vice President | Aug 09 | Option Exercise | 34.94 | 40,000 | 1,397,600 | 178,991 | Aug 13 07:11 PM | | PEDERSON MICHAEL J | Senior Vice President | Aug 09 | Sale | 86.39 | 23,008 | 1,987,705 | 81,220 | Aug 13 07:12 PM | | YOOR BRIAN B | Executive Vice President & CFO | Aug 08 | Option Exercise | 38.03 | 43,763 | 1,664,357 | 158,144 | Aug 09 05:05 PM | | YOOR BRIAN B | Executive Vice President & CFO | Aug 08 | Sale | 85.77 | 43,763 | 3,753,706 | 114,381 | Aug 09 05:05 PM | | Blount Sally E. | Director | Jul 31 | Sale | 87.65 | 2,500 | 219,121 | 26,266 | Aug 02 05:01 PM | | WOODGRIFT RANDEL WILLIAM | Senior Vice President | Jul 24 | Option Exercise | 38.40 | 65,000 | 2,496,000 | 117,562 | Jul 26 09:30 PM | | WOODGRIFT RANDEL WILLIAM | Senior Vice President | Jul 24 | Sale | 88.01 | 65,000 | 5,720,325 | 52,562 | Jul 26 09:30 PM | | Salvadori Daniel Gesua Sive | Executive Vice President | Jun 26 | Option Exercise | 38.40 | 71,000 | 2,726,400 | 167,148 | Jun 27 05:01 PM | | Salvadori Daniel Gesua Sive | Executive Vice President | Jun 26 | Sale | 84.00 | 71,000 | 5,964,007 | 96,148 | Jun 27 05:01 PM | | Wainer Andrea F | Executive Vice President | Jun 21 | Sale | 85.13 | 1,188 | 101,134 | 41,260 | Jun 24 05:59 PM | | ALLEN HUBERT L | Executive Vice President | Jun 20 | Option Exercise | 34.94 | 165,000 | 5,765,100 | 311,010 | Jun 21 05:19 PM | | CAPEK JOHN M | Executive Vice President | Jun 20 | Option Exercise | 26.19 | 46,900 | 1,228,213 | 355,435 | Jun 21 05:20 PM | | CAPEK JOHN M | Executive Vice President | Jun 20 | Sale | 85.00 | 46,900 | 3,986,500 | 308,535 | Jun 21 05:20 PM | | ALLEN HUBERT L | Executive Vice President | Jun 20 | Sale | 85.00 | 165,000 | 14,025,000 | 146,010 | Jun 21 05:19 PM | | Salvadori Daniel Gesua Sive | Executive Vice President | Jun 13 | Sale | 82.00 | 3,331 | 273,142 | 96,148 | Jun 13 05:12 PM | | LANE ANDREW H | Executive Vice President | Jun 12 | Option Exercise | 48.90 | 73,424 | 3,590,434 | 119,362 | Jun 14 05:03 PM | | LANE ANDREW H | Executive Vice President | Jun 12 | Sale | 81.42 | 73,424 | 5,978,197 | 45,938 | Jun 14 05:03 PM | | Salvadori Daniel Gesua Sive | Executive Vice President | Jun 11 | Sale | 82.00 | 7,269 | 596,058 | 99,479 | Jun 13 05:12 PM |
|
